Literature DB >> 7197160

Properties of two urate oxidases modified by the covalent attachment of poly(ethylene glycol).

R H Chen, A Abuchowski, T Van Es, N C Palczuk, F F Davis.   

Abstract

Poly(ethylene glycol) of 5 000 daltons has been attached covalently to preparations of urate oxidase (urate: oxygen oxidoreductase, EC 1.7.3.3) from hog liver and Candida utilis. Attachment of sufficient poly(ethylene glycol) to either urate oxidase renders the enzyme incapable of eliciting antibody production in mice, or of reacting with antibodies to the unmodified enzyme. The poly(ethylene glycol) : urate oxidase conjugates exhibit higher Km and lower V values than the unmodified urate oxidases. Optimal pH values are increased for the poly(ethylene glycol) : urate oxidases, and optimal temperatures are decreased. The blood circulating lives of the modified urate oxidases following intravenous injection are much longer than those of the unmodified urate oxidases: repetitive injections over a period of 90 days dd not alter the blood circulating lives of the poly(ethylene glycol) : urate oxidases. The unmodified enzymes, on the other hand, were cleared from the blood with extreme rapidity after a few intravenous injections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7197160     DOI: 10.1016/0005-2744(81)90173-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

2.  Tolerogenic activity of polyethylene glycol-conjugated lysozyme distinct from that of the native counterpart.

Authors:  H O Ito; T So; M Hirata; T Koga; T Ueda; T Imoto
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

Review 3.  Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?

Authors:  M L Shiffman
Journal:  Curr Gastroenterol Rep       Date:  2001-02

4.  Xanthine oxidase inhibits growth of Plasmodium falciparum in human erythrocytes in vitro.

Authors:  P A Berman; L Human; J A Freese
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 5.  Polymer conjugates. Pharmacokinetic considerations for design and development.

Authors:  R Duncan; F Spreafico
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

6.  Impact of large aggregated uricases and PEG diol on accelerated blood clearance of PEGylated canine uricase.

Authors:  Chun Zhang; Kai Fan; Xuefeng Ma; Dongzhi Wei
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

7.  Altered biodistribution of an antibody--enzyme conjugate modified with polyethylene glycol.

Authors:  E A Eno-Amooquaye; F Searle; J A Boden; S K Sharma; P J Burke
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

Review 8.  Site-Specific PEGylation of Therapeutic Proteins.

Authors:  Jonathan K Dozier; Mark D Distefano
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

9.  Improved biological properties and hypouricemic effects of uricase from Candida utilis loaded in novel alkaline enzymosomes.

Authors:  Qun-You Tan; Jing-Qing Zhang; Na Wang; Hong Yang; Xiaoling Li; Hua-Rong Xiong; Jian-Yong Wu; Chun-Jing Zhao; Hong Wang; Hua-Feng Yin
Journal:  Int J Nanomedicine       Date:  2012-07-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.